期刊文献+

高危型皮肤鳞状细胞癌治疗的研究进展 被引量:5

下载PDF
导出
摘要 皮肤鳞状细胞癌(cSCC)是世界范围内最常见的非黑色素瘤皮肤癌之一。根据cSCC的特征及病人自身情况,将其分为高危型和低危型。cSCC大部分为低危型,容易治疗,但高危型cSCC可有较高的复发率和致死率。本文主要综述高危型cSCC近年来在临床治疗方面的最新研究进展。
出处 《齐鲁医学杂志》 2016年第2期246-248,251,共4页 Medical Journal of Qilu
基金 青岛市科技发展指导计划项目(KJZD-13-32-JCH)
  • 相关文献

参考文献29

  • 1KARIA P S, JAMBUSARIA-PAHLAJANI A, HARRING- TON D P, et al. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma[J]. J Clin Oncol, 2014,32(4):327-334.
  • 2ROSS A S, WHALEN F M, ELENITSAS R, et al. Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study[J]. Dermatoi Surg, 2009,35 (12) 1859-1866.
  • 3LIU L S, COLEGIO O R. Molecularly targeted therapies for nonmelanoma skin cancers[J]. Int J Derrnatol, 2013,52 (6) : 654-665.
  • 4BRANTSCH K D, MEISNER C, SCHONFISCH B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study[J]. Lancet On- col, 2008,9(8) :713-720.
  • 5SMITH K J, HAMZA S, SKELTON H. Histologic features in primary cutaneous squamous cell carcinomas in immuno- compromised patients focusing on organ transplant patients [J]. Dermatol Surg, 2004,30(4 Pt 2):634-641.
  • 6MARTORELL-CALATAYUD A, SANMARTIN JIMENEZ O, CRUZ MOJARRIETA J, et al. Cutaneous squamous cell carcinoma: defining the high-risk variant[J]. Actas Dermosi- filiogr, 2013,104(5) : 367-379.
  • 7ROWE D E, CARROLL R J, DAY C L, et al. Prognostic fac- tors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection[J]. J Am Acad Dermatol, 1992,26(6) :976-990.
  • 8O'BRYAN K, SHERMAN W, NIEDT G W, et al. An evol- ving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma[J]. J Am Acad Dermatol, 2013,69 (4) : 595-602.
  • 9YOON D Y, HWANG H S, CHANG S K, et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the as- sessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck[J]. Eur Radiol, 2009,19(3): 634-642.
  • 10JAMBUSARIA-PAHLAJANI A, HESS S D, KATZ K A, et al. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mobs surgeons[J]. Arch Dermatol, 2010,146(11) :1225-1231.

二级参考文献25

  • 1DISPENZIERI A C. Chemotherapy induced insulin dependent diabetes mellitus[J]. Clinical Oneology, 1997, 15 (3) : 1287- 1288.
  • 2GOLDSTEIN R S, MAYOR G H, GINGERICH R L, et al. The effects of cisplatin and other divalent platinum compounds on glucose metabolism and pancreatic endocrine function[J]. Toxicology and Applied Pharmacology, 1983,69(3):432 -441.
  • 3GOLDSTEIN R S, MAYOR G H, ROSENBAUM R W, et al. Glucose intolerance following cis-platinum treatment in rats [J]. Toxicology, 1982,24(3-4) :273-280.
  • 4GHAVAMZADEH A, LARIJANI B, JAHANI M, et al Thyroid, parathyroid, gonadal, and pancreatic beta-cell func tion after bone marrow transplantation with chemotherapy-on ly conditioning[J]. Transplantation Proceedings, 2003,35 (8) 3101 3104.
  • 5CVETKOVIC l, MILJKOVIC D, VUCKOVIC O, et al. Ta xol activates inducible nitric oxide synthase in rat astrocytes: the role of MAP kinases and NF-kappaB[J]. Cellular and Mo- lecular Life Sciences: CMLS, 2004,61(10).-1167-1175.
  • 6MOSN H, SALEHI A, HENNINGSSQN R, et al. Nitric oxide inhibits, and carbon monoxide activates, islet acid a[pha- glueoside hydrolase activities in parallel with glucose-stimula- ted insulin secretion[J]. The Journal of Endocrinology, 2006, 190(3) : 681-693.
  • 7THOMAS L E, THOMAS W H. Protection of NIT 1 pan- creatic β-cells from immune attack by inhibition of NF-kB[J]. Journal of Autoimmunity, 1997(10) 293 298.
  • 8HO E, CHEN G, BRAY T M. Alpha-phenyl-tert-butylnitrone (PBN) inhibits NFkappaB activation offering protection against chemically induced diabetes[J]. Free Radical Biology & Medicine, 2000,28(4) 604-614.
  • 9KUMAR A, NEGI G, StlARMA S S. Suppression of NF-kB and NF-kB regulated oxidative stress and neuroinflammation by BAY 11-7082 (IkB phosphorylation inhibitor) in experimental diabetic neuropathy[J]. Biochimie, 2012,94(5) :1158-1165.
  • 10BARZILAY J I, ABRAHAM L, HECKBERT S R, et al. The relation of markers of inflammation to the development of glu- cose disorders in the elderly: the Cardiovascular Health Study [J]. Diabetes, 2001,50(10) 2384-2389.

共引文献3

同被引文献39

  • 1高天文,孙东杰,李春英,何弘,李青,刘友生,刁庆春,黄高升,郝飞,钟白玉,马福成,柳凤轩,闫小初,刘东梅,刘玉峰,刘荣卿.中国西部两医院1905例皮肤恶性肿瘤回顾分析[J].北京大学学报(医学版),2004,36(5):469-472. 被引量:73
  • 2张武,王昕,李铮,于娜.唇部鳞状细胞癌误诊为口唇单纯疱疹1例[J].中国误诊学杂志,2005,5(13):2590-2591. 被引量:1
  • 3袁敬东,李云霞,胡琼华.颜面部皮肤恶性肿瘤26例手术治疗体会[J].实用癌症杂志,2006,21(4):426-427. 被引量:5
  • 4王玮.整形外科学[M].浙江科学技术出版社,2007.
  • 5Kallini JR, NouranHamed MD, FACMS AKMDF. Squamous cell carcinoma of the skin : epidemiology, classification, management, and novel trends[J]. Int J Dermatol, 2015,54(2) :130-140.
  • 6Analysis of risk factors determining prognosis of cutaneous squa- mous-cell carcinoma: a prospective study [ J ]. Lancet Oncol, 2008,9(7) :713-720.
  • 7Stratigos A, Garbe C, Lebbe C, et al. Diagnosis and treatment of invasive squamous cell carcinoma of the skin : European consensus- based interdisciplinary guideline [ J ]. Eur J Cancer, 2015,5l(14):1989-2007.
  • 8Bonerandi JJ, Beauvillain C, Caquant L, et al. Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma and precursor lesions [ J]. J Eur Acad Dermatol Venereol, 2011, 25 Suppl 5 : 1-51.
  • 9Newlands C, Gurney B. Management of regional metastatic disease in head and neck cutaneous malignancy. 2. Cutaneous malignant melanoma[J]. Br J Oral Maxillofac Surg, 2014,52(4):301-307.
  • 10Iyer NG, Clark JR, Murali R, et al. Outcomes following parotld- ectomy for metastatic squamous cell carcinoma with microscopic residual disease: implications for facial nerve preservation [ J ]. Head Neck, 2009,31 ( 1 ) :21-27.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部